2026

Compounds in 2026: Emerging Science, and the Future of Bioactive Therapeutics

Executive Overview Peptides have rapidly evolved from a specialized pharmaceutical category into one of the most strategically important therapeutic classes worldwide. Historically limited to applications such as insulin therapy and select hormonal treatments, peptides now sit at the center of innovation across metabolic health, longevity science, regenerative medicine, and performance optimization. As of 2026, the […]

MNM ProLabs

Compounds in 2026—Why Your Supplier Matters

Compounds have moved from “interesting biomolecules” to core tools across drug discovery, diagnostics, delivery science, and biomedical method development. In 2026, the headline is not just “more Compounds,” but better compound engineering: improved design, more realistic predictive modeling, stronger delivery concepts, and accelerating work in targeted conjugates and macrocyclic formats. At the same time, the […]